CAY10566, available orally, has shown promising anticancer effects in glioblastoma xenografts [203] and prevents ovarian cancer spheroid formation by reducing PI3K/AKT phosphorylation [70]. The gene discussed is AKT1; the disease is ovarian carcinoma.